4//SEC Filing
Weisblum Eric 4
Accession 0001213900-25-113104
CIK 0001514183other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 4:00 PM ET
Size
7.4 KB
Accession
0001213900-25-113104
Insider Transaction Report
Form 4
Weisblum Eric
DirectorPres, Chief Compliance Officer
Transactions
- Purchase
Common Stock
2025-11-19$0.41/sh+4,500$1,823→ 209,932 total - Purchase
Common Stock
2025-11-18$0.40/sh+7,500$3,025→ 205,432 total
Footnotes (2)
- [F1]This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions on November 18, 2025 at prices ranging from $0.4000 to $0.4050. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions on November 19, 2025 at prices ranging from $0.3975 to $0.4100. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Silo Pharma, Inc.
CIK 0001514183
Entity typeother
Related Parties
1- filerCIK 0001569077
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 4:00 PM ET
- Size
- 7.4 KB